A Multicenter, Randomized, Double-Blind, Placebo and Active Controlled Study Comparing the Analgesic Efficacy and Safety of ABT-639 to Placebo in Subjects With Diabetic Neuropathic Pain.
Phase of Trial: Phase II
Latest Information Update: 07 Dec 2016
At a glance
- Drugs ABT 639 (Primary) ; Pregabalin
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Therapeutic Use
- Sponsors Abbott Laboratories; AbbVie
- 07 Nov 2011 Additional locations (Czech Republic, France, Germany, Mexico) added as reported by ClinicalTrials.gov.
- 07 Nov 2011 Actual end date (October 2011) added as reported by ClinicalTrials.gov.
- 07 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.